357 related articles for article (PubMed ID: 29050400)
1. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
[TBL] [Abstract][Full Text] [Related]
2. TRAP1 rescues PINK1 loss-of-function phenotypes.
Zhang L; Karsten P; Hamm S; Pogson JH; Müller-Rischart AK; Exner N; Haass C; Whitworth AJ; Winklhofer KF; Schulz JB; Voigt A
Hum Mol Genet; 2013 Jul; 22(14):2829-41. PubMed ID: 23525905
[TBL] [Abstract][Full Text] [Related]
3. Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson's disease.
Costa AC; Loh SH; Martins LM
Cell Death Dis; 2013 Jan; 4(1):e467. PubMed ID: 23328674
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
[TBL] [Abstract][Full Text] [Related]
5. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
Plun-Favreau H; Klupsch K; Moisoi N; Gandhi S; Kjaer S; Frith D; Harvey K; Deas E; Harvey RJ; McDonald N; Wood NW; Martins LM; Downward J
Nat Cell Biol; 2007 Nov; 9(11):1243-52. PubMed ID: 17906618
[TBL] [Abstract][Full Text] [Related]
7. What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease?
Plun-Favreau H; Gandhi S; Wood-Kaczmar A; Deas E; Yao Z; Wood NW
Ann N Y Acad Sci; 2008 Dec; 1147():30-6. PubMed ID: 19076428
[TBL] [Abstract][Full Text] [Related]
8. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.
Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R
Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo.
Yun J; Cao JH; Dodson MW; Clark IE; Kapahi P; Chowdhury RB; Guo M
J Neurosci; 2008 Dec; 28(53):14500-10. PubMed ID: 19118185
[TBL] [Abstract][Full Text] [Related]
11. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
[TBL] [Abstract][Full Text] [Related]
12. Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin.
Tain LS; Chowdhury RB; Tao RN; Plun-Favreau H; Moisoi N; Martins LM; Downward J; Whitworth AJ; Tapon N
Cell Death Differ; 2009 Aug; 16(8):1118-25. PubMed ID: 19282869
[TBL] [Abstract][Full Text] [Related]
13. HtrA2 deficiency causes mitochondrial uncoupling through the F₁F₀-ATP synthase and consequent ATP depletion.
Plun-Favreau H; Burchell VS; Holmström KM; Yao Z; Deas E; Cain K; Fedele V; Moisoi N; Campanella M; Miguel Martins L; Wood NW; Gourine AV; Abramov AY
Cell Death Dis; 2012 Jun; 3(6):e335. PubMed ID: 22739987
[TBL] [Abstract][Full Text] [Related]
14. A novel role for the mitochondrial HTRA2/OMI protease in aging.
Kang S; Fernandes-Alnemri T; Alnemri ES
Autophagy; 2013 Mar; 9(3):420-1. PubMed ID: 23242108
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis.
Dagda RK; Chu CT
J Bioenerg Biomembr; 2009 Dec; 41(6):473-9. PubMed ID: 20012177
[TBL] [Abstract][Full Text] [Related]
16. Commentary: Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
Rai SN; Singh SS; Birla H; Zahra W; Rathore AS; Singh P; Singh SP
Front Aging Neurosci; 2018; 10():221. PubMed ID: 30108499
[No Abstract] [Full Text] [Related]
17. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.
Strauss KM; Martins LM; Plun-Favreau H; Marx FP; Kautzmann S; Berg D; Gasser T; Wszolek Z; Müller T; Bornemann A; Wolburg H; Downward J; Riess O; Schulz JB; Krüger R
Hum Mol Genet; 2005 Aug; 14(15):2099-111. PubMed ID: 15961413
[TBL] [Abstract][Full Text] [Related]
18. HtrA2/Omi influences the stability of LON protease 1 and prohibitin, proteins involved in mitochondrial homeostasis.
Goo HG; Rhim H; Kang S
Exp Cell Res; 2014 Nov; 328(2):456-65. PubMed ID: 25094062
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.
Moisoi N; Klupsch K; Fedele V; East P; Sharma S; Renton A; Plun-Favreau H; Edwards RE; Teismann P; Esposti MD; Morrison AD; Wood NW; Downward J; Martins LM
Cell Death Differ; 2009 Mar; 16(3):449-64. PubMed ID: 19023330
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.
Gaki GS; Papavassiliou AG
Neuromolecular Med; 2014 Jun; 16(2):217-30. PubMed ID: 24522549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
